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Abstract
Background: Mood disorder accounts for 13 % of global disease burden. And while therapeutic agents are available,
usually orally administered, most have unwanted side effects, and thus making the inhalation of essential oils (EOs) an
attractive alternative therapy. Rosmarinus officinalis EO (ROEO), Mediterranean ROEO reported to improve cognition,
mood, and memory, the effect on stress of which has not yet been determined. Here, the anti-stress effect of ROEO on
stress was evaluated in vivo and in vitro.
Methods: Six-week-old male ICR mice were made to inhale ROEO and subjected to tail suspension test (TST). To
determine the neuronal differentiation effect of ROEO in vitro, induction of ROEO-treated PC12 cells differentiation was
observed. Intracellular acetylcholine and choline, as well as the Gap43 gene expression levels were also determined.
Results: Inhalation of ROEO significantly decreased the immobility time of ICR mice and serum corticosterone level,
accompanied by increased brain dopamine level. Determination of the underlying mechanism in vitro revealed a PC12
differentiation-induction effect through the modulation of intracellular acetylcholine, choline, and Gap43 gene expression
levels. ROEO activates the stress response system through the NGF pathway and the hypothalamus-pituitary-adrenal axis,
promoting dopamine production and secretion. The effect of ROEO may be attributed to its bioactive components,
specifically to α-pinene, one of its major compounds that has anxiolytic property.
Conclusions: The results of this study suggest that ROEO inhalation has therapeutic potential against stress-related
psychiatric disorders.
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Background
Emotional disorders, including depression, cause a huge
burden on health worldwide. Several theories to explain
the pathogenesis of depression have been proposed but
because of the complexity, identification of specific
mechanism of depression has been difficult. However,
evidences suggest that stress and depression are associ-
ated with atrophy and loss of neuronal cells, as well as
reduction in the volume of key brain structures. Chronic
exposure to stress, for example, induces neuronal in-
flammation, neuronal degeneration, and brain micro-
damage [1]. Recently approved antidepressants, such as
serotonin selective reuptake inhibitors (SSRIs) or anxio-
lytics that are mostly administrated orally, are found to
exert better therapeutic efficacy than previous medica-
tions. However, the unwanted side effects of these drugs,
such as the amnestic effect of benzodiazepine [2], have
not yet been entirely eradicated and their molecular and
therapeutic mechanisms are not fully understood [3]. To
resolve concerns on limited efficacy of existing drugs,
new antidepressant agents or alternative agents with
novel mechanisms that are more effective and without
or fewer side effects are sought.
Essential oils (EOs) have a long history of use as folk
medicine and are still attractive as a therapeutic agent
against oxidative stress [4], tumorigenesis [5], stress-
related disorders including depression and anxiety [6].
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Both anecdotal and empirical literature reports some
major EOs, on the psychological or behavioral effects,
however the effect of many EOs remained largely undis-
covered. Rosmarinus officinalis is herb used for culinary
and medicinal purposes that contains polyphenols such
as rosmarinic acid, carnosic acid, and luteolin and other
water-soluble phytochemicals that exert several effects
on psychiatric diseases or neurological function includ-
ing neuroprotective, cognitive properties, anti-depressive
and anti-anxiety effects [7–9]. R. officinalis EO (ROEO)
has been reported to exhibit anti-proliferative, antioxi-
dant and antibacterial activities [10], as well as improve-
ment of cognition, mood, and memory function in
healthy adults [11] and improvement of locomotor activ-
ity in mice [12]. Oral intake of ROEO showed anti-
depressant-like effect in mice [13] but EOs terpenoids
and ketones often exhibit acute toxicity even in very low
concentration [14]. Inhalation of EO as a sedative
[15–17], anxiolytic [18–20] and anti-stress [6, 21] ther-
apy ensures effectivity without unwanted side effects and
has an advantage in terms of the absence of pathological
consequences on organs and tissues [14]. The effective-
ness and detailed mechanism of inhalation of ROEO on
psychological and neurological function however,
remains unknown.
Here, we evaluated the effect of ROEO inhalation on
the molecular mechanism by which ROEO alleviates
stress in vitro using PC12 cells and in vivo using ICR
mice, a mice strain widely used for behavioral tests.
Psychiatric functions and neurophysiological mechanism
were determined in vivo using tail suspension test
(TST), and measurement of the catecholamine and
corticosterone level, while the effect on neuronal differ-
entiation was determined using activity of acetylcholin-
esterase (AChE) and neuronal elongation as indicators,
in vitro. We hypothesized that ROEO actively enhance
the neuronal activity in mice by promoting cell
differentiation.
Methods
Preparation of essential oil (EO) samples
The Rosmarinus officinalis L. leaves collected from
Matmata, Tunisia that were used in the extraction of the
R. officinalis essential oil (ROEO) used in this study and
authenticated by Prof. Mohamed Neffati (Arid Land
Institute, Tunisia). Voucher specimens of the Rosemary
leaf samples (UT-ARENA-00323) used in this study were
deposited in the Alliance for Research on North Africa,
University of Tsukuba, Japan. ROEO was extracted from
dried plant material (leaves) by hydrodistillation method,
and kept in the dark at 4 °C until use. Pure EO of laven-
der (Lavandula angustifolia) (LAEO) and almond
(Prunus dulcis) oil (AL) were purchased from Sigma
(St Louis, MO, USA) and Wako Pure Chemical
Industries, Ltd., (Osaka, Japan), respectively.
ROEO components were analyzed using Agilent 6890 N
Network gas chromatographic (GC) system gas chromato-
graph equipped with a HPMS 5973 mass spectrometer
with a HP-5MS fused silica column (30 m × 0.25 mm ID,
film thickness 0.25 μm, Hewlett-Packard; carrier gas was
helium adjusted to a linear velocity of 34 cm/s). The oven
temperature program was the same as that used for the
HP-5 column for GC-FID analysis: source temperature
was 230 °C, quadrupole temperature was 150 °C, injector
and detector was 250 °C and 280 °C respectively. Samples
(0.1 μl) were injected with a split ratio of 1:100. The
composition of the ROEO was identified by GCMS and
the main components of the ROEO were identified to be
camphor (20.42%), alpha-pinene (10.49%), beta-pinene
(10.21%) (Table 1).
Animals
Six-week-old male ICR mice were used in this study
(Charles River Laboratories Japan Inc., Yokohama,
Kanagawa, Japan) and were housed individually in poly-
carbonate cage lined with paper bedding (Palsoft,
Oriental Yeast Co., Ltd., Tokyo, Japan) and with a stain-
less steel wire cover. The mice were given access to
water and food ad libitum under a 12/12 h light/dark
cycle in a temperature- and humidity-controlled animal
facility of the Gene research Center of the University of
Tsukuba. Before the experiments, animals were allowed
to acclimatize to laboratory condition for 1 week and
were randomly assigned to experimental groups. Each
mouse was sacrificed by cervical spine dislocation. Blood
was collected and blood serum was collected by centri-
fugation at 2000×g for 10 min. Brain samples were col-
lected and washed with PBS (−), then immediately
immersed in liquid nitrogen and kept at −80 °C until
use. The experiments performed in this study were
Table 1 GCMS analysis of the components of the R. officinalis
essential oil (ROEO)
Compound RT Amount present
ROEO (%)
Alpha-pinene 6.449 10.49
Beta-pinene 6.788 10.21
Camphene 7.360 3.13
O-cymene 8.515 3.56
Camphor 11.258 20.42
Borneol 11.644 5.57
Terpineol-4 11.835 2.25
Bornyl acetate 14.011 4.46
Alpha-eudesmol 20.662 2.38
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approved by the Animal Care and Use Committee of the
University of Tsukuba.
EO inhalation method
EOs were dropped on the piece of cotton (Chiyoda,
Osaka, Japan) placed on the upper part of the chamber
before putting the mice inside the chamber (30 cm×
23 cm× 15 cm) [6] and allowed to inhale the EO for
30 min. Control group mice (n = 6) were placed in the
chamber without the EOs. The volume of EOs that dif-
fused in the chamber are as follows: 100 μl LAEO (n = 8),
100 μl AL (n = 8) and 50 μl ROEO (n = 8) or 100 μl ROEO
(n = 8). AL was used as a negative control while LAEO
was the positive control. The mice inhaled the EOs every
day for 14 days. All mice have never been exposed to EO
prior to this study.
Tail suspension test (TST)
TST, a widely accepted method used for screening of an-
tidepressants or anxiolytics in rodents, was performed
following the method described by [22] Cavanagh et al.
(2002). After EO inhalation, the mice were suspended
for 6 mins by taping the tail to the hooks attached to the
ceiling of the apparatus (30 × 15 × 50 cm; L ×W×H)
and their immobility time in the last 4 min was re-
corded, as described previously [8]. The immobility time
measurement starts when the mice show no movement
without postural distortion. TST was performed every
other day for 2 weeks, the order of the treatment and
testing was also done not in any particular order
(random) until all the mice have been treated or tested.
Serum corticosterone assay
Serum corticosterone (ng/ml) level was determined
using AssayMax Corticosterone ELISA kit (AssayPro
LLC, Saint Charles, MO, USA) following the manufac-
turer’s instructions. The serum was prepared as
described previously [9]. Briefly, blood was centrifuged
for 10 min at 2000×g to collect the serum samples which
were stored in -80 °C prior to analysis. The cortico-
sterone level was calculated based on the standard curve
prepared using corticosterone standard reagent included
in the kit.
Dopamine (DOP), noradrenaline (NAD) and adrenaline
(ADR) assay
Mice brains were collected and 100 mg sections of
hippocampus and cerebral cortex were taken for ana-
lysis. To prepare the samples for analysis, 100 μl of dis-
tilled water was added to each sample, followed by
homogenization for 1 min on ice. For the analysis of
dopamine (DOP), noradrenaline (NAD) and adrenaline
(ADR) levels, 3-CAT Research ELISA (LDN, Nordhorn,
Niedersachsen, Germany) was used following the manu-
facturer’s instructions.
Cell culture and sample preparation
PC12 cells (Riken, Tsukuba, Ibaraki, Japan) were main-
tained in Dulbecco’s Modified Eagle Medium (DMEM)
(Sigma) supplemented with 5% heat-inactivated fetal bo-
vine serum (FBS) (Bio West, USA), 10% heat-inactivated
horse serum (HS) (Invitrogen, New Zealand) and 50 U/ml
penicillin, 50 μg/ml streptomycin (Lonza Inc.,
Walkersville, MD, USA) and incubated at 37 °C in a hu-
midified incubator with 5% CO2. The cells between
passages 3 and 8 were used for the experiments. ROEO
was sterilized by filtration (0.22 μm filter) and emulsified
in growth medium, diluted with 10% volume of ethanol,
and homogenized on ice prior to use. Nerve growth factor
7 s (NGF) (Sigma) was diluted in the growth medium at
50 ng/ml.
Assessment of cell viability
Cell viability was assessed using 3-(4, 5-dimethylthiazol-
2-yl)-2, 5- diphenyltetrazolium bromide (MTT) assay.
PC12 cells were seeded at 1 × 105 cells/ml into poly
L-lysine-coated 96-well plates (Wako). After overnight
incubation, cells were treated with or without ROEO at
5, 10, 50 and 100 μg/ml for 48 h. MTT assay was then
performed by adding 10 μl of MTT (Dojindo, Japan) so-
lution and incubating the cells further for 24 h at 37 °C
in the dark., followed by addition of 100 μl of 10% SDS
(Wako) and incubation for 24 h. The absorbance at
570 nm was determined using a multidetection micro-
plate reader (Powerscan HT, Dainippon Pharmaceutical,
Osaka, Japan). The viability of PC12 cells was calculated
as percentage of control.
Acetylcholinesterase (AChE) assay
Differentiating PC12 cells synthesize neurotransmitters
that can be used as a marker of neuronal differenti-
ation. PC12 cells were cultured as described above and
treated without or with nerve growth factor (NGF), the
positive control, or 10 μg/ml ROEO and incubated
further for 48 h. The effect of ROEO on neuronal dif-
ferentiation, using AChE assay, was performed as previ-
ously reported [23].
Determination of intracellular choline (Ch) and acetylcholine
(ACh) levels
The intracellular concentration of ACh and Ch in PC12
cells was measured using Ultimate 3000 Dionex HPLC
coupled with electro-chemical detector (ECD). PC12
cells were seeded at 1 × 105 cells/ml into 10-cm dish and
incubated overnight. Then, cells were treated as de-
scribed above and washed with PBS(−) twice and col-
lected by trypsination. Cells were homogenized in 15%
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formic acid in acetone and centrifuged at 12,000×g, 4 °C
for 15 min. The supernatant was evaporated using a vac-
uum centrifuge (SCRUM Inc., Japan) and the precipitate
dissolved in 100 μl of milliQ water and filtered and
analyzed for intracellular level of ACh and Ch using
AFpack ACH-494 column (4.6 mm ID ×10 mm L)
(Shodex, Japan) was used. The amount of ACh and Ch
was measured as described previously [9].
Measurement of growth associated factor 43 (Gap43) gene
expression
To reveal the effect of ROEO on neuronal differentiation
at the transcription level, the expression of Gap43 gene
was quantified using real-time PCR. PC12 cells were
seeded and treated as described above. After treatment,
the cells were washed with PBS(−) twice and detached by
gently scraping the cells. RNA was extracted using
ISOGEN (NIPPON GENE CO. Ltd) following the manu-
facture’s instruments. Reverse transcription was
performed using Superscript III reverse transcriptase kit
(Invitrogen, Carlsbad, CA, USA) and amplified using 2720
Thermal Cycler (Applied Biosystems, USA). Real-time
PCR amplification reactions were performed using an
AB7500 Fast real-time system (Applied Biosystems). Using
the following cycling conditions: 2 min at 50 °C, 10min at
95 °C, and 40 cycles of 15 s at 95 °C/1min at 60 °C.
Specific for rat growth associated protein 43 (Gap43)
(Rn01474579_m1) and Gapdh (Rn01775763_g1) were
purchased from Applied Biosystems.
Effect of ROEO on differentiated neuronal cells
To determine the effect of ROEO on neuronal cells,
PC12 cells were treated with 50 ng/ml NGF (NGF) to
induce the cells to differentiate while untreated cells
served as the control. The cells were then incubated fur-
ther for 24 h, followed by treatment with (NGF + ROEO)
or without 10 μg/ml ROEO (ROEO) for 48 h. The level
of AChE, which indicates the induction activity of neur-
onal differentiation of PC12 cells, was then quantified
using the AChE assay. AChE activity was assessed using
the protocol described above.
Statistical analysis
All the results were expressed as mean ± standard devi-
ation. Statistical analysis was performed using Student’s
t-test. Comparisons between groups were carried out using
one way analysis of variance (ANOVA) (One-Way
ANOVA, Inferential Statistics Computational Suite version
10.4.0) followed by a pairwise comparison using the JMP
Statistical Discovery software from SAS version 13.2.0.
P ≤ 0.05 was considered to be statistically significant.
Results
ROEO alleviated TST-induced stress in vivo
To assess the effect of ROEO inhalation on mice behav-
ior, specifically on stress, TST was performed. TST is a
well-accepted method for measuring stress in mice as
well as their reaction to anti-depressants, with the im-
mobility time considered as the behavioral index of
animal’s ability for coping with stressful stimuli [24]. As
shown in Fig. 1a, ROEO treatment at 50 μl/day and
100 μl/day decreased the immobility time to 20.13 s and
8.92 s, respectively, in comparison with the control
(76.17 s). The average immobility time of the almond oil
(AL) group was not significantly different compared to
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Fig. 1 Effect of Rosmarinus officinalis essential oil (ROEO) on mice
immobility time in tail suspension test (TST), and serum corticosterone
level. a Effect of ROEO on the immobility time of mice in tail suspension
test (TST). Mice were made to inhale the EOs for 30 min daily for 2
weeks. The volume of EO for each experiment was 100 μl for almond oil
(AL) and lavender EO (LAEO), and 50 or 100 μl for ROEO. During the
two-week inhalation of EO, TST was performed every other day
measuring the immobility time at the last 4 min of the six-min TST
session. Data represent the average result of the TST performed on
the last day of the experiment. Each result represents the mean
± .SD (n = 5). *P≤0.05, **P≤0.01 vs. control. b Effect of ROEO on
mice serum corticosterone level. At the end of the two-week EO
inhalation, mice were sacrificed and serum was collected. Serum
corticosterone level was quantified using an ELISA kit (AssayMax
Corticosterone ELISA Kit, AssayPro LLC, Saint Charles, MO, USA) as
described in Materials and Methods. Data represent the mean of
±.SD (n = 3). *P≤0.05, **P≤0.01 vs. control
Villareal et al. BMC Complementary and Alternative Medicine  (2017) 17:549 Page 4 of 10
the control (61.75 s) while L. angustifolia EO (LAEO)
decreased it to 17.36 s. Pairwise comparison analysis re-
sults revealed that LAEO, the positive control, was not
was not significantly different to 50 and 100 μL ROEO
(P = 0.59 and 0.53, respectively). Analysis of variance
results showed significant differences in the immobility
time between treatment groups (P = 0.0076). The body
weight and the overall health condition of the animals and
the amount of feeds consumed were measured throughout
the duration of the study and no significant difference
among all groups was recorded (data not shown).
ROEO modulated the activity of HPA axis and brain
catecholamine level in vivo
With the observed decrease in immobility time, we then
wanted to verify if this was a result of any effect of
ROEO on the HPA axis activity. Chronic elevated serum
corticosterone level is an indication of hyperactivity of the
HPA axis, which may lead to depressive-like behaviors,
which increases immobility time in TST [24].
Corticosterone is a hormone associated with stress and is
secreted when the hypothalamus-pituitary-adrenal (HPA)
axis is activated [25]. The corticosterone levels of mice
groups treated with 50 μl/day or 100 μl/day ROEO were
33.8 ng/ml and 35.3 ng/ml, respectively (Fig. 1b). The
effect was not significant for the AL mice group
(43.1 ng/ml) compared with the control group (44. 2 ng/ml).
For LAEO group, the corticosterone level was
31.83 ng/ml. Mice that inhaled 50 μl/day and 100 μl/
day ROEO and LAEO had significantly lower cortico-
sterone level compared to the AL group. ROEO at
50 μl/day treatment showed lower corticosterone level
compared to LAEO and was the most effective among
these groups. The level of dopamine (DOP), noradren-
aline (NAD) and adrenaline (ADR) in the mice brain
were also evaluated and presented in Table 2.
ROEO at 50 μl/day and 100 μl/day had significantly
improved DOP level compared to the control
(333.86 ng/100 mg). AL did not have significant effect
on the levels of the neurotransmitters. Like ROEO,
LAEO also improved the DOP level. Compared with
LAEO (792.03 ng/g), both ROEO treatment groups
showed lower DOP concentration (653.56 ng/100 mg
and 765.52 ng/100 mg for 50 μl/day and 100 μl/day, re-
spectively). With regards to the NAD levels, no signifi-
cant effect was observed in ROEO (507.36 ng/100 mg
and 46.64 ng/100 mg in 50 μl/day and 100 μl/day,
respectively) group but a significant improvement was
observed in LAEO group (55.29 ng/100 mg) compared
with control group (44.31 ng/100 mg). For ADR, ROEO
group did not show significant change (0.35 ng/100 mg
and 0.34 ng/100 mg, in 50 μl/day and 100 μl/day ROEO,
respectively), as with LAEO group (0.44 ng/100 mg
LAEO) group compared to the control group (0.33 ng/
100 mg). Both ROEO treatment groups showed lower
level of ADR compared with LAEO. Inhalation of ROEO
(50 μl/day and 100 μl/day) showed significant effects on
serum brain DOP level. ANOVA results showed signifi-
cant differences in the DOP levels between groups
(Table 2).
ROEO promoted acetylcholinesterase (AChE) activity and
upregulated Gap43 mRNA expression in PC12 cells
Observed improved corticosterone and dopamine levels,
which could be due to neuronal differentiation, was ob-
served following ROEO inhalation. To verify if ROEO
induced neuronal differentiation, acetylcholinesterase
(AChE) activity and the expression of Gap43 mRNA
expression in PC12 cells were determined. First, the
non-cytotoxic concentration of ROEO was determined
by performing MTT assay. PC12 cells were treated with
or without ROEO (0, 5, 10, 50, and 100 μg/ml) for 48 h.
MTT assay results showed that ROEO was not cytotoxic
at low concentrations (5 and 10 μg/ml) but was slightly
cytotoxic at 50 and 100 μg/ml, decreasing the cell viabil-
ity to 97% and 81.41% for 50 and 100 μg/ml ROEO,
respectively.
The synthesis and secretion of neurotransmitters are
significant events associated with neuronal differenti-
ation. In PC12 cells, the secretion of acetylcholine (ACh)
is induced following induction of PC12 cell differenti-
ation. Treatment with μg/ml ROEO increased the AChE
activity in PC12 (124.16%) compared both the control
(100%) and 50 ng/ml NGF (116.36%) (Fig. 2b). Since
ACh is produced from ingested choline (Ch) and from
recycled choline in the synapse, we then determined the
intracellular concentration of ACh and its substrate Ch
using HPLC-ECD. As presented in Table 3, ROEO in-
creased the intracellular ACh and Ch levels to 11.88 ng/
mg and 2645.49 ng/mg, respectively. As expected, NGF
increased the intracellular ACh (11.99 ng/mg) and Ch
levels (2660.6 ng/mg) compared to the control. The con-
trol had ACh and Ch levels of 9.51 ng/mg and
2156.21 ng/mg, respectively.
To further investigate the effects of ROEO on neur-
onal differentiation, the gene expression level of growth-
Table 2 Catecholamine, dopamine (DOP), noradrenaline (NAD)
and adrenaline (ADR) levels in mice brain (ng/100 mg brain tissue)1
Group DOPa NADb ADRb
Control 333.86 ± 12.32 44.31 ± 2.73 0.33 ± 0.057
AL 443.1 ± 5.65 48.81 ± 2.64 0.31 ± 0.051
LAEO 792.03 ± 14.49 * 55.29 ± 3.18 * 0.44 ± 0.042
ROEO 50 653.56 ± 8.22 * 50.74 ± 4.86 0.35 ± 0.071
ROEO 100 765.52 ± 12.92 * 46.64 ± 4.51 0.34 ± 0.067
1Data represent the mean ± SD. *P ≤ 0.05, **P ≤ 0.01 vs. control; aP ≤ 0.01
significant differences between groups, bnot significant differences between
groups (ANOVA)
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associated protein 43 (Gap43) was determined. Quanti-
tative real-time PCR results showed that NGF treatment
significantly increased the Gap43 expression by 38% by
ROEO and by 57.37% compared to the control (Fig. 3a).
ROEO treatment (10 μg/ml) and NGF treatment (50 ng/
ml) induced PC12 cells to undergo neuronal outgrowth
elongation as shown in Fig. 3b. And to evaluate the ef-
fect of ROEO on PC12 cells differentiation in vitro, cells
NGF-differentiated cells were treated with ROEO and its
effect on AChE expression was evaluated. AChE assay
results showed that compared to the control (untreated
cells), differentiated cells (+NGF) treated with 10 μg/ml
ROEO significantly increased the AChE activity by
40.7% while treatment with NGF alone or ROEO treat-
ment increased the AChE activity by only 12.9% and
21.5%, respectively (Fig. 4).
Discussion
The demand for therapeutics for the cure and preven-
tion of mental and neurological diseases has increased
recently mainly due to the fact that most orally adminis-
trated drugs have adverse side effects. One alternative
therapy that is gaining a lot of popularity is inhalation of
essential oils (EOs) and fragrant compounds, the reports
for which indicate their potential therapeutic effects on
behavior, and on the serum corticosteroid and brain
neurotransmitter levels [6, 19, 26, 27]. In the present
study, the effect of ROEO on stress response system, in-
cluding HPA axis and brain neurotransmitters, was eval-
uated. R. officinalis L. has been reported to activate
cholinergic activity, as well as neuroprotective and anti-
depressive effects [8, 23]. TST results revealed that
ROEO could significantly decrease the mice immobility
time by at least 50 s compared to the control mice
(Fig. 1a). The same effect was observed in mice exposed
to one of the positive controls, LAEO (17.36 s), and this
effect was attributed to (−)-linalool, one of its active
components that can decrease mice immobility time in
TST [28]. TST and forced swimming test (FST) are well-
known behavioral tests for assessing anti-depressant ac-
tivity. TST was chosen to evaluate the effect of ROEO
because of its several advantages compared to the FST.
In FST the difference in the swimming ability of each
animal can influence the results, and hypothermia may
be also be induced [29]. Using TST, various antidepres-
sant or anxiolytic medications have been demonstrated
to decrease the immobility and promoted the escape-
related behavior [24, 29]. The decreased immobility time
observed in ROEO and LAEO inhalation suggests that
they also have anti-stress effect.
The HPA axis is a key response system against
stressors and plays an important role in the pathophysi-
ology of stress-related mental disorders. Chronic stress
results from high glucocorticoids level with the hyper-
activity of HPA axis triggering several physiological
adaptive feedback regulation mechanism [1, 30]. ROEO
lowered the serum corticosterone level comparable to
LAEO (Fig. 1b) and this result suggests that ROEO
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Fig. 2 Effect of Rosmarinus officinalis essential oil (ROEO) on PC12
cell proliferation and acetylcholinesterase activity. a Effect of ROEO
on PC12 cells viability. PC12 cells were seeded onto 96-well plates at
a density of 1×105 cells/ml. After overnight incubation, cells were
treated with 0, 5, 10, 50 or 100 μg/ml ROEO for 48 h and the cell
viability was evaluated using MTT assay. Data are presented as a
percentage of the control and represent the mean of three
independent trials ±.SD *P≤0.05 vs. control. b Effect of ROEO on
the acetylcholinesterase (AChE) activity in PC12 cells. PC12 cells
were seeded onto 96-well plates at a density of 1×105 cells/ml.
After overnight incubation, cells were treated with 50 ng/ml of
nerve growth factor (NGF) or 10 μg/ml of ROEO for 48 h. The control
indicates cells incubated for 48 h without NGF or ROEO treatment.
AChE activity was expressed in percentage of control. Data represent
the mean of three independent trials ±.SD *P≤0.05, **P<≤0.01
vs. control
Table 3 Intracellular acetylcholine (ACh) and choline (Ch) level
in PC12 cells (ng/mg) a
Group Control NGF (50 ng/ml) ROEO (10 μg/ml)
Total choline
(Ch)
2156.21 ± 237.73 2660.6 ± 178.16 * 2645.49 ± 244.18*
Acetylcholine
(ACh)
9.51 ± 1.13 11.99 ± 2.78* 11.88 ± 2.26*
aData represent the mean ± .SD. *P ≤ 0.05, **P ≤ 0.01 vs. control
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suppressed the activity of HPA axis increased by TST-
induced stress.
ROEO regulated the brain catecholamine level, signifi-
cantly increasing only the DOP level whereas LAEO
increased the DOP, NAD, and ADR levels (Table 2), con-
sistent with previous reports on LAEO [31]. The activity
of sympathetic neuron is essential for coping with stress
and is part of the stress response system. Studies have
established the relationship between the amount of cat-
echolamine in the brain and psychiatric diseases, a
decrease in DOP level, specifically, is observed in indi-
viduals suffering from depression [32]. The brain cat-
echolamine levels suggest that the anti-stress effect of
ROEO appears to be different from that of LAEO, indi-
cating a possible difference in the mechanism involved
for these oils. Significant enhancement of memory was
observed in ROEO-administered mice but not in LAEO
group. Both essential oils, however, have been observed
to have significant improvement on cognitive perform-
ance and mood in 144 healthy volunteers [11]. However,
the effect of LAEO may be more similar to benzodiaze-
pines in that it enhances the effects of gamma-
aminobutyric acid in the amygdala region [22].
EOs may be administrated orally or as intraperitoneal
injection, but inhalation is preferred with respect to
safety and benefits. Fragrant compounds reach the cen-
tral nervous system (CNS) through the olfactory and
respiratory systems, introducing the drug by axonal
transport or activity of perineural channels [33]. Orally
administrated drugs usually have considerable acute oral
toxicity [34].
Modulation of function of neuronal cells, like neuro-
transmission and synaptic plasticity, is directly correlated
with the regulation of stress response systems, thereby
preventing stress-related neurological diseases.
a
b
Fig. 3 Effect of Rosmarinus officinalis essential oil (ROEO) on the PC12 cells neuronal outgrowth elongation.PC12 cells were seeded onto 96-well plates
at a density of 1×105 cells/ml. After overnight incubation, PC12 cells were treated with 50 ng/ml of nerve growth factor (NGF) or 10 μg/ml of ROEO for
48 h. Control cells were incubated for 48 h without NGF or ROEO treatment. a Expression of growth associated protein 43 (Gap43) mRNA quantified
using real-time PCR and normalized to Gapdh mRNA expression. Data represent the mean of three independent trials ±.SD *P≤0.05, **P≤0.01 vs.
control. b Morphology of PC12 cells treated without (Control) or with 50 ng/ml NGF (NGF) or 10 μg/ml of ROEO (ROEO). The photographs were taken
48 h after sample treatment and arrows point to cells with dendritic morphology. Photographs of the cells at 200× magnification were taken using a
phase contrast microscope equipped with DFC 290HD camera (Leica Microsystem). The scale-bar represents 50 μm
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Fig. 4 Effect of Rosmarinus officinalis essential oil (ROEO) on
acetylcholinesterase (AChE) activity in differentiated PC12 cells. PC12
cells were seeded onto 96-well plates at a density of 1×105 cells/ml
and were pre-treated with 50 ng/ml nerve growth factor (NGF) for
24 h before treatment with 10 μg/ml of ROEO for 48 h without (ROEO)
or with 10 ng/ml NGF (RO + NGF). AChE activity was expressed as
percentage of control. Data are presented as a percentage of the
control and represent the mean of three independent trials ±.SD
*P≤0.05, **P≤0.01 vs. control
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Corticosterone hypersecretion, however, suppress the
production of neurotrophic factors NGF and brain-
derived neurotrophic factor (BDNF) [35]. NGF and
BDNF are known to induce neuronal differentiation but
cannot cross the blood brain barrier (BBB) easily, and
thus, are metabolized by peptidases when administered
peripherally [36]. However, when inhaled, some of the
compounds present in EOs can reach the CNS, which
suggests the possibility of inhalation of EOs as a better
alternative therapy for neurological diseases [37–39].
Some of the active components of major EOs have been
reported to pass the BBB, and this includes α-pinene
that is present in ROEO [40]. Inhaled α-pinene has been
shown to have anxiolytic effect in mice [41], and as one
of the effective compounds in ROEO, α-pinene contrib-
uted to the observed effects of inhaled ROEO, but for
the other compounds, synergistic effect of various com-
pounds in the EO might have contributed to the effect
[10] (Bakkali et al., 2008).
PC12 cells are known to differentiate into autonomic
neuron-like cells, gaining function for neurotransmitter
production, and elongation of neurite outgrowth when
treated with NGF or NGF-like substances [42]. In this
study, PC12 was used to evaluate the effect of the ROEO
on neuronal differentiation. ROEO significantly in-
creased both ACh and Ch levels (Table 3). Secreted ACh
was observed to be higher in differentiated PC12 cells
following ROEO treatment suggesting that the enzym-
atic activity of AChE was due to ROEO treatment
(Fig. 2b). It can also be noted that in undifferentiated
PC12 Ach was increased by ROEO, even without NGF
to induce differentiation, providing further evidence of
its differentiation induction effect that was also shown in
Fig. 3b. In the ACh synthesis pathway, the uptake of Ch,
regulated by the activity of choline acetyl transferase
(ChAT), is the rate-limiting step [43]. AChE activity has
been demonstrated to be affected in animal model of
stress, so that an increase in the intracellular Ch and
ACh level, following activation of AChE, the observed
enhanced ACh synthesis and secretion was caused by
the inhaled ROEO (Fig. 2b).
Growth associated protein 43 (Gap43) is a marker of
neuronal outgrowth elongation as its expression is asso-
ciated with neuronal differentiation, neuroplasticity and
neuronal outgrowth elongation [44, 45]. ROEO upregu-
lated Gap43 expression and thus, provided additional
evidence for its ability to induce neuronal differentiation
(Fig. 4). Moreover, AChE activity in differentiated PC12
cells was significantly increased by ROEO treatment,
suggesting its ability to promote cholinergic function fol-
lowing neuronal differentiation. ROEO is likely to exert
an effect similar to NGF and it can be assumed that the
mechanism of the effect of ROEO on neuronal cells
might be related to NGF-mediated signaling pathways
such as through ERK1/2, PI3K/AKT, and protein kinase
C (PKC) which activity is reported to correlate with the
survival of existing neuronal cells and neuronal cell dif-
ferentiation [42]. Although the results have shown sig-
nificant improvement in the mice’s stress levels
following inhalation of ROEO, the procedure for the
introduction of the EOs can be made more efficient by
using a face mask-like instrument to ensure that the
mice will be introduced to more EOs.
Conclusions
The results of this study have shown that inhalation of
ROEO alleviates stress by decreasing serum cortico-
sterone level and increasing brain DOP level in vivo,
suggesting that ROEO can regulate the activities of the
HPA axis and sympathetic nerve system. Furthermore,
in vitro, ROEO modulates brain neurotransmitter activ-
ity, exerts neurophysiological effect related with the ac-
tivity of ACh synthesis and secretion, and induce
neuronal differentiation. The increase in Gap43 mRNA
expression, in addition to elevation in the stress response
and neuronal plasticity, further suggests the role of the
HPA axis in ROEO’s anti-stress effect. A clinical trial
may be useful in assessing the validity of the results in
clinical depression. The results presented here suggest
that ROEO has a potential for use as a safe alternative
treatment for stress-related mood disorders.
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